BioLife Sciences Inc. (BLFE)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - 411.69 Thousand - - -
Cost of Revenue - - 1.39 Million - - -
Gross Profit - - -984.54 Thousand - - -
Operating Expenses - - 259.16 Thousand - 42.28 Thousand 329.13 Thousand
Selling, General and Administrative Expenses - - 259.16 Thousand - 42.28 Thousand 329.13 Thousand
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses - - 1.65 Million - 42.28 Thousand 329.13 Thousand
Operating Income - - -1.24 Million - -42.28 Thousand -329.13 Thousand
Interest Expense - - 49.32 Thousand - 10.43 Thousand 11.25 Thousand
Income Tax Expense - - -206.29 Thousand - - -
Earnings before Tax - - -1.26 Million -1134.00 -52.71 Thousand -340.38 Thousand
Net Income - - -1.26 Million -1134.00 -52.71 Thousand -340.38 Thousand
Earnings Per Share Basic - - -0.02 -0.00 -0.00 -0.08
Earnings Per Share Diluted - - -0.02 -0.00 -0.00 -0.08
Weighted Average Shares Outstanding - - 51.77 Million 19.45 Million 19.45 Million 4.45 Million
Weighted Average Shares Outstanding (Diluted) - - 51.77 Million 19.45 Million 19.45 Million 4.45 Million
Gross Margin - - -2.39 - - -
EBIT Margin - - -3.02 - - -
Profit Margin - - -3.08 - - -
EBITDA - - -1.24 Million 171.86 Thousand -42.28 Thousand -329.13 Thousand
Earnings Before Tax Margin - - -3.02 - - -

Income Statement Charts